论文部分内容阅读
天津天士力制药集团有限公司成立于1994年5月10日,是一个以制药工业为主业,以天然植物药研究、标准化加工生产相配套发展的高科技企业。集团以科技创新为基点,确立“创传统医药的第一品牌,创民族制药的高科技型企业”的发展战略目标,坚持“高科技为核心、市场为导向,营销为动力,质量为保障”,并建立了一整套“以人为本”的现代企业管理制度和运行机制。在1997年12月9日,国家十八部委组成的全国医药卫生领导小组在京宣布:我国第一个中药,也是世界上第一例复方天然药——天士力复方丹参滴丸按照FDA新药审批程序,通过FDA-IND的审查,直接进入新药Ⅰ,Ⅱ期合并试验后,按照FDA的要求,从药品来源做起,组建了我国第一个按照国际GAP标准的丹参药源基地,确保了中药来源的质量。
Tianjin Tasly Pharmaceutical Group Co., Ltd. was established on May 10, 1994. It is a high-tech enterprise focusing on the pharmaceutical industry, and researching and standardizing processing and production of natural botanicals. With scientific and technological innovation as the basic point, the Group establishes the development strategic goal of “creating the first brand of traditional medicine and creating a high-tech enterprise of national pharmaceutical”, insisting on “high-tech as the core, market-oriented, marketing as the driving force, and quality as the guarantee”. And established a set of “people-oriented” modern enterprise management system and operating mechanism. On December 9, 1997, the National Leading Group for Medicine and Health of 18 National Ministries announced in Beijing: China’s first Chinese medicine, and also the world’s first compound natural medicine - Tasly Compound Danshen Dripping Pills. According to the FDA’s new drug approval procedure, After reviewing the FDA-IND directly into the new drug phase I and phase II trials, according to the requirements of the FDA, starting from the drug source, we established the first Danshen drug source base in accordance with international GAP standards to ensure the origin of traditional Chinese medicine. quality.